Literature DB >> 19752300

Comparison of risk factor profiles in incidental Lewy body disease and Parkinson disease.

Roberta Frigerio1, Hiroshige Fujishiro, Demetrius M Maraganore, Kevin J Klos, Anthony DelleDonne, Michael G Heckman, Julia E Crook, Keith A Josephs, Joseph E Parisi, Bradley F Boeve, Dennis W Dickson, J Eric Ahlskog.   

Abstract

OBJECTIVE: To explore whether associations of potential risk factors for incidental Lewy body disease (iLBD) are similar to those for Parkinson disease (PD).
DESIGN: Brain autopsy study (1988-2004) of subjects without evidence of neurodegenerative disease or tremor who were evaluated by at least 1 physician within 1 year of death. Researchers analyzed incidental Lewy pathology blinded to clinical abstraction.
SETTING: Olmsted County, Minnesota. Subjects Residents of Olmsted County and the immediate vicinity aged older than 60 years. MAIN OUTCOME MEASURES: Whether risk factors previously associated with PD in Olmsted County are also associated with iLBD.
RESULTS: Of 235 subjects, 34 had iLBD (14.5%). The overall risk factor profiles for iLBD and PD were fairly similar between the 2 sets of odds ratio (OR) estimates, with 11 of 16 ORs in the same direction. Prior Olmsted County studies documented 7 risk factors with statistically significant associations with PD; for physician occupation and caffeine intake, the ORs for iLBD were in the same direction and statistically significant, whereas for education, head injury, and number of children, they were in the same direction but not significant; they were in the opposite direction but not statistically significant for depression and anxiety. Incidental Lewy body disease was not associated with various end-of-life conditions or causes of death, though these patients were slightly older and more likely cachectic.
CONCLUSIONS: Based on this exploratory study, iLBD and PD appear to have similar risk factor profiles. Thus, at least some cases of iLBD could represent preclinical PD, arrested PD, or a partial syndrome due to a lesser burden of causative factors. Incidental Lewy body disease is not explained by nonspecific end-of-life brain insults.

Entities:  

Mesh:

Year:  2009        PMID: 19752300      PMCID: PMC2813519          DOI: 10.1001/archneurol.2009.170

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  37 in total

Review 1.  What is the evidence for a premorbid parkinsonian personality: a systematic review.

Authors:  Lianna Ishihara; Carol Brayne
Journal:  Mov Disord       Date:  2006-08       Impact factor: 10.338

2.  Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology.

Authors:  Heiko Braak; Rob A I de Vos; Jürgen Bohl; Kelly Del Tredici
Journal:  Neurosci Lett       Date:  2005-12-05       Impact factor: 3.046

3.  Association of olfactory dysfunction with incidental Lewy bodies.

Authors:  G Webster Ross; Robert D Abbott; Helen Petrovitch; Caroline M Tanner; Daron G Davis; James Nelson; William R Markesbery; John Hardman; Kamal Masaki; Lenore Launer; Lon R White
Journal:  Mov Disord       Date:  2006-12       Impact factor: 10.338

4.  Education and occupations preceding Parkinson disease: a population-based case-control study.

Authors:  R Frigerio; A Elbaz; K R Sanft; B J Peterson; J H Bower; J E Ahlskog; B R Grossardt; M de Andrade; D M Maraganore; W A Rocca
Journal:  Neurology       Date:  2005-11-22       Impact factor: 9.910

5.  Alpha-synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects.

Authors:  A Bloch; A Probst; H Bissig; H Adams; M Tolnay
Journal:  Neuropathol Appl Neurobiol       Date:  2006-06       Impact factor: 8.090

6.  Comorbid conditions associated with Parkinson's disease: a population-based study.

Authors:  Cynthia L Leibson; Demetrius M Maraganore; James H Bower; Jeanine E Ransom; Peter C O'brien; Walter A Rocca
Journal:  Mov Disord       Date:  2006-04       Impact factor: 10.338

7.  Number of children and risk of Parkinson's disease.

Authors:  Roberta Frigerio; Monique M B Breteler; Lonneke M L de Lau; Kevin R Sanft; James H Bower; J Eric Ahlskog; Brandon R Grossardt; Demetrius M Maraganore; Walter A Rocca
Journal:  Mov Disord       Date:  2007-04-15       Impact factor: 10.338

8.  Insights into REM sleep behavior disorder pathophysiology in brainstem-predominant Lewy body disease.

Authors:  B F Boeve; D W Dickson; E J Olson; J W Shepard; M H Silber; T J Ferman; J E Ahlskog; E E Benarroch
Journal:  Sleep Med       Date:  2006-12-06       Impact factor: 3.492

9.  Parkinson's disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons.

Authors:  Heiko Braak; Magdalena Sastre; Jürgen R E Bohl; Rob A I de Vos; Kelly Del Tredici
Journal:  Acta Neuropathol       Date:  2007-02-09       Impact factor: 17.088

10.  Bowel movement frequency in late-life and incidental Lewy bodies.

Authors:  Robert D Abbott; G Webster Ross; Helen Petrovitch; Caroline M Tanner; Daron G Davis; Kamal H Masaki; Lenore J Launer; J David Curb; Lon R White
Journal:  Mov Disord       Date:  2007-08-15       Impact factor: 10.338

View more
  18 in total

Review 1.  Pathologic correlates of dementia in individuals with Lewy body disease.

Authors:  Joshua A Sonnen; Nadia Postupna; Eric B Larson; Paul K Crane; Shannon E Rose; Kathleen S Montine; James B Leverenz; Thomas J Montine
Journal:  Brain Pathol       Date:  2010-05       Impact factor: 6.508

Review 2.  Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: no.

Authors:  Uwe Walter
Journal:  J Neural Transm (Vienna)       Date:  2010-12-29       Impact factor: 3.575

3.  Prospective study of restless legs syndrome and mortality among men.

Authors:  Yanping Li; Wei Wang; John W Winkelman; Atul Malhotra; Jing Ma; Xiang Gao
Journal:  Neurology       Date:  2013-06-12       Impact factor: 9.910

4.  Nigral pathology and parkinsonian signs in elders without Parkinson disease.

Authors:  Aron S Buchman; Joshua M Shulman; Sukriti Nag; Sue E Leurgans; Steven E Arnold; Martha C Morris; Julie A Schneider; David A Bennett
Journal:  Ann Neurol       Date:  2012-02       Impact factor: 10.422

Review 5.  Idiopathic REM sleep behaviour disorder in the development of Parkinson's disease.

Authors:  Bradley F Boeve
Journal:  Lancet Neurol       Date:  2013-04-09       Impact factor: 44.182

6.  Incidental Lewy body disease: electrophysiological findings suggesting pre-clinical Lewy body disorders.

Authors:  John N Caviness; Charles H Adler; Joseph G Hentz; Holly A Shill; Virgilio G H Evidente; Erika D Driver-Dunckley; Marwan N Sabbagh; Lucia Sue; Thomas G Beach
Journal:  Clin Neurophysiol       Date:  2011-05-26       Impact factor: 3.708

Review 7.  Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease.

Authors:  Isidre Ferrer; Anna Martinez; Rosa Blanco; Ester Dalfó; Margarita Carmona
Journal:  J Neural Transm (Vienna)       Date:  2010-09-23       Impact factor: 3.575

Review 8.  The potential of induced pluripotent stem cells as a translational model for neurotoxicological risk.

Authors:  Kevin K Kumar; Asad A Aboud; Aaron B Bowman
Journal:  Neurotoxicology       Date:  2012-02-11       Impact factor: 4.294

9.  Locus coeruleus neuron density and parkinsonism in older adults without Parkinson's disease.

Authors:  Aron S Buchman; Sukriti Nag; Joshua M Shulman; Andrew S P Lim; Veronique G J M VanderHorst; Sue E Leurgans; Julie A Schneider; David A Bennett
Journal:  Mov Disord       Date:  2012-10-04       Impact factor: 10.338

10.  Risk factors for dementia with Lewy bodies: a case-control study.

Authors:  Brendon P Boot; Carolyn F Orr; J Eric Ahlskog; Tanis J Ferman; Rosebud Roberts; Vernon S Pankratz; Dennis W Dickson; Joseph Parisi; Jeremiah A Aakre; Yonas E Geda; David S Knopman; Ronald C Petersen; Bradley F Boeve
Journal:  Neurology       Date:  2013-07-26       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.